Meyka Pro banner
Sitio Royalties Corp.

Stay Updated with the Latest Sitio Royalties Corp. STR News in Real Time

Find STR news now at Meyka AI. Stay informed with the latest Sitio Royalties Corp. stocks updates, including price news, market analysis, and expert insights.

STRNYSE
Basic MaterialsIndustrial Materials
$18.12
$0.18(0.98%)
U.S. Market opens in 64h 37m
Mizuho Sues Radiant World in Singapore Court as Police Probe Widens
📅 11 hours ago

Mizuho Sues Radiant World in Singapore Court as Police Probe Widens

Singapore police raid Radiant World’s office investigating falsified documents. Mizuho Bank files court injunction against the iron ore trader on August 28 as five banks discover fake invoices.

Read more 12
Samsung Affiliates Face 45% Premium Offer for S-1 Stake as Activist Investor Pushes Landmark Deal
📅 1 day ago

Samsung Affiliates Face 45% Premium Offer for S-1 Stake as Activist Investor Pushes Landmark Deal

Samsung affiliates received a formal buyout offer for their combined stake in S-1 Corp on August 27, 2026. Singapore-based Flashlight Capital Partners proposed acquiring the 20.6% stake at 116,000 won per share. That price represents a 45% premium to Wednesday’s closing price. The deal totals 906.6 billion won, or $655 million, testing South Korea’s revised…

Read more 12
Welspun Corp Shares Tumble 6% as ₹1,433 Crore Block Deal Changes Hands
📅 2 days ago

Welspun Corp Shares Tumble 6% as ₹1,433 Crore Block Deal Changes Hands

Welspun Corp shares tumbled up to 5.94% to ₹2,206.10 on the NSE on August 26, 2026. The drop followed a ₹1,433.44 crore block deal in the morning trading window. MD & CEO Vipul Mathur and promoter group entity Welspun Investments and Commercials were among the sellers in the transaction. The stock had closed at ₹2,345.50…

Read more 12
Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech  
📅 4 days ago

Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech  

Hanmi Pharm shares surged 30% on August 24, 2026, hitting the daily price limit after the South Korean drugmaker announced a licensing deal with Genentech worth up to $2.3 billion. The agreement covers HM17321, an experimental obesity treatment designed to reduce body fat while preserving muscle mass. Hanmi will receive $190 million upfront, while Genentech…

Read more 12
Welspun Corp (WELCORP) Share Price Soars 16% to Record High After ₹17,200 Crore Mega Order
📅 7 days ago

Welspun Corp (WELCORP) Share Price Soars 16% to Record High After ₹17,200 Crore Mega Order

On August 21, 2026, Welspun Corp shares surged after the company won its largest-ever single order, valued at about $1.8 billion (₹17,200 crore). The contract covers pipe supplies from its US manufacturing facility and sent the stock to a record high. The deal also pushed Welspun Corp’s global order book to around $4.4 billion, giving…

Read more 12
Asics to Dissolve Trading Subsidiary, Consolidate Walking Business August 15
📅 14 days ago

Asics to Dissolve Trading Subsidiary, Consolidate Walking Business August 15

Asics will liquidate its trading subsidiary and consolidate walking operations. Q2 profit jumped 62.1% to 35.6 billion yen as Onitsuka Tiger brand drives growth.

Read more 12
Intel (NASDAQ: INTC) Upsizes Stock Offering to $20 Billion at $95 a Share, Stock Gains 1% Premarket
📅 17 days ago

Intel (NASDAQ: INTC) Upsizes Stock Offering to $20 Billion at $95 a Share, Stock Gains 1% Premarket

Intel Corporation priced an upsized $20 billion common stock offering on August 11, 2026. The chipmaker sold 210,526,315 shares at $95 per share, up from an initial $15 billion target announced Monday. Intel shares gained about 1% in premarket trading Tuesday, recovering after Monday’s 4% drop. The deal reflects surging demand for Intel’s foundry buildout…

Read more 12
QVC Exits Bankruptcy With $5B Debt Cut, Mike George Returns as CEO on August 7
📅 20 days ago

QVC Exits Bankruptcy With $5B Debt Cut, Mike George Returns as CEO on August 7

QVC exits bankruptcy with $5 billion debt reduction and $600 million new credit facility. Former CEO Mike George returns to lead turnaround as company relists on Nasdaq under symbol QVCG.

Read more 12
First Phosphate Uplists ADRs to Nasdaq on August 10, 2026
📅 20 days ago

First Phosphate Uplists ADRs to Nasdaq on August 10, 2026

First Phosphate uplists Level 2 ADRs to Nasdaq Global Market under ticker PHOS on August 10, 2026. The move converts OTCQX holdings automatically and maintains a 10-to-1 ADR ratio.

Read more 12

STR News FAQ